Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 9B (PPP1R9B)

Target
PPP1R9B
Molecular classification
Scaffold protein, Enzyme regulator (regulatory subunit), Cytoskeletal-associated protein
01

Overview

Protein phosphatase 1 regulatory subunit 9B (PPP1R9B), also known as Spinophilin or Neurabin-2, is a scaffold protein highly expressed in dendritic spines of the central nervous system. It acts as a regulatory subunit for protein phosphatase 1 (PP1), modulating excitatory synaptic transmission and dendritic spine morphology. PPP1R9B binds actin filaments and serves as a linker between the cytoskeleton and the plasma membrane at synaptic junctions. Through targeting PP1 to specific subcellular locations, PPP1R9B confers substrate specificity for processes including ion channel regulation, glutamate receptor function (AMPA and NMDA types), and G-protein coupled receptor signaling (dopamine D2, alpha-adrenergic receptors). It also plays a role in cell migration and is implicated in tumor suppression, schizophrenia, and limbic encephalitis.

Other names
Neurabin-2SpinophilinNeurabin-IIPPP1R6PPP1R9SPINOSpn
02

Mechanism of action

Agents modulating PPP1R9B (not clinically available) would function by altering PP1 localization/activity, synaptic transmission, or receptor signaling. Drugs affecting dopamine receptor activity might indirectly interact with PPP1R9B functions, but none specifically target PPP1R9B at present.

03

Biological functions

Regulation of protein phosphatase 1 activityModulation of excitatory synaptic transmissionDendritic spine morphology and plasticityActin filament binding and cytoskeletal linkageRegulation of G-protein coupled receptor signalingDopaminergic neurotransmissionCell migration (HGF-induced)
04

Disease associations

SchizophreniaLimbic encephalitisTumor suppression (decreased expression observed in tumors)Potential implications in other neuropsychiatric and neurodegenerative diseases (due to central role in synaptic function and signal transduction)
05

Safety considerations

Potential CNS side effects if targeted, due to broad role in synaptic transmission and dendritic spine morphologyRisk of neuropsychiatric effects from perturbation of dopamine-related pathwaysEffects on cell migration and cytoskeletal dynamics may pose off-target risks
06

Biomarkers

PPP1R9B expression levels in certain tumors (reduced in some cancers)Possibly synaptic markers in brain studies, though not used clinically as a biomarker

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 9B (PPP1R9B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 9B (PPP1R9B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call